In the β2 band, similar to the effect in β1 band, rPSD in MS patients with CNP increased as compared with HC (p < 0.001) and MS patients without CNP (p < 0.001) as accounted by the ANOVA main effect group [F(2, 527) = 13.293; p < 0.001; η2 = 0.045] (Figure 2B). The gene discussed is CNP; the disease is myeloid sarcoma.